Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen (Q70585757)
Jump to navigation
Jump to search
scientific article published on 01 January 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen |
scientific article published on 01 January 1992 |
Statements
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen (English)
E Garcia-Giralt
Y Ayme
M Carton
A Daban
T Delozier
P Fargeot
P Fumoleau
A Gorins
D Guerin
1 reference
1 reference
1 reference
1 reference